UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | O | P | R | S | T | W | Z
Number of items: 115.

A

Adams, M and Calvert, AH and Carmichael, J and Clark, PI and Coleman, RE and Earl, HM and Gallagher, CJ and Ganesan, TS and Gore, ME and Graham, JD and Harper, PG and Jayson, GC and Kaye, SB and Ledermann, JA and Osborne, RJ and Perren, TJ and Poole, CJ and Radford, JA and Rustin, GJS and Slevin, ML and Smyth, JF and Thomas, H and Wilkinson, PM (1998) Chemotherapy for ovarian cancer - a consensus statement on standard practice. BRIT J CANCER , 78 (11) 1404 - 1406.

Almassy, R and Bowman, K and Calvert, AH and Curtin, NJ and Golding, BT and Hostomska, Z and Hostomsky, Z and Griffin, RJ and Maegley, K and Newell, DR and Srinivasan, S and White, AW and Webber, S (1998) 2-phenylbenzimidazole-4-carboxamides are potent inhibitors of the DNA repair enzyme poly(ADP-ribose)-polymerase (PARP). ANN ONCOL , 9 30 - 31.

Almassy, R and Bowman, K and Calvert, AH and Curtin, NJ and Golding, BT and Hostomska, Z and Hostomsky, Z and Griffin, RJ and Maegley, K and Newell, DR and Srinivasan, S and White, AW and Webber, S (1998) 2-phenylbenzimidazole-4-carboxamides are potent inhibitors of the DNA repair enzyme poly(ADP-ribose)-polymerase (PARP). Annals of Oncology , 9 116 - ?.

B

Begent, RHJ and Napier, MP and Sharma, SK and Springer, CJ and Bagshawe, KD and Green, AJ and Martin, J and Stribbling, SM (1998) Antibody-directed enzyme prodrug therapy (ADEPT). ANN ONCOL , 9 23 - 23.

Begent, RHJ and Napier, MP and Sharma, SK and Springer, CJ and Bagshawe, KD and Green, AJ and Martin, J and Stribbling, SM (1998) Antibody-directed enzyme prodrug therapy (ADEPT). Annals of Oncology , 9 64 - 64.

Bhatia, J and Pedley, RB and Sharma, SK and Boxer, GM and Read, DA and Boden, RW and Michael, P and Chester, KA and Begent, RHJ (1998) A distribution study at sub-millimetre resolution of a recombinant MFE-23 : CPG(2) fusion protein in a colorectal cancer xenograft model. BRIT J CANCER , 78 61 - 61.

Bhatia, J and Pedley, RB and Sharma, SK and Boxer, GM and Read, DA and Boden, RW and Michael, P and Chester, KA and Begent, RHJ (1998) A distribution study at sub-millimetre resolution of a recombinant MFE-23:CPG(2) fusion protein in a colorectal cancer xenograft model. British Journal of Cancer , 78 147 - 147.

Bhatia, J and Pedley, RB and Sharma, SK and Boxer, GM and Read, DA and Michael, P and Boden, RW and Chester, KAAB and R, HJ (1998) A distribution study at sub-millimetre resolution of a recombinant MFE:CPG2 fusion protein in a colorectal cancer xenograft model. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 61 - ?).

Bhhhhhatia, J and Pedley, RB and Sharma, SK and Boxer, GM and Read, DA and Boden, RW and Michael, P and Chester, KA and Begent, RHJ (1998) A distribution study at sub-millimetre resolution of a recombinant MFE-23:CPG(2) fusion protein in a colorectal cancer xenograft model. In: (Proceedings) British Journal of Cancer. (pp. 147 - 147).

Botelli, R and Tibballs, J and Hochhauser, D and Watkinson, A and Dick, R and Burroughs, AK (1998) Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice. CLIN RADIOL , 53 (10) 713 - 716.

Boxer, GM and Mayer, A and O'Malley, D and Tsiompanou, E and Winslet, MC and Lewis, AAM and Dhillon, AP and Hilson, AJW and Begent, RHJ (1998) Radioimmunoguided surgery (RIGS) of colorectal cancer with single chain Fv antibody to CEA. BRIT J CANCER , 78 10 - 10.

C

Calvert, AH and Walling, JM (1998) Clinical studies with MTA. BRIT J CANCER , 78 35 - 40.

Caroline, R (1998) My cancer and the magic bullet. UNSPECIFIED

Casey, JL and King, DJ and Pedley, RB and Boden, JA and Boden, R and Chaplin, LC and Dorning, M and Begent, RHJ (1998) Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle. BRIT J CANCER , 78 (10) 1307 - 1312.

Cassoni, AM and Whelan, JS (1998) Ewing's sarcoma: hyperfractionated radiotherapy with concurrent chemotherapy: acute toxicity. A prospective single institutional study. In: 4th Symposium of the Connective Tissue Oncology Society, Vancouver Nov 1998.

Cooke, SP and Lawrence, L and Boxer, GM and Chester, KA and Begent, RHJ (1998) Phage-derived single chain Fv antibody fragments to vascular endothelial cell growth factor. In: British Journal of Cancer. (pp. 91 - 91).

Cooke, SP and Lawrence, L and Boxer, GM and Chester, KA and Begent, RHJ (1998) Phage-derived single chain Fv antibody fragments to vascular endothelial cell growth factor. BRIT J CANCER , 78 47 - 47.

Cummings, J and Spanswick, VJ and Gardiner, J and Ritchie, A and Smyth, JF (1998) Pharmacological and biochemical determinants of the antitumour activity of the indoloquinone EO9. BIOCHEM PHARMACOL , 55 (3) 253 - 260.

Cummings, J and Spanswick, VJ and Ritchie, AA and Smyth, JF (1998) Pharmacological determinants of the antitumour activity of mitomycin C - implications for enzyme directed drug development. ANN ONCOL , 9 134 - 134.

Cummings, J and Spanswick, VJ and Tomasz, M and Smyth, JF (1998) Enzymology of mitomycin C metabolic activation in tumour tissue - Implications for enzyme-directed bioreductive drug development. BIOCHEM PHARMACOL , 56 (4) 405 - 414.

D

deKretser, D and Skakkebaek, NE and Wylie, CC and Harland, SJ and Oosterhuis, JW (1998) Germ cell cancer and disorders of spermatogenesis: An environmental connection? Discussion. Apmis , 106 12 - 12.

Dische, S and Saunders, MI (1998) Hypoxic cell radiosensitiation- clinical relevance in1998. In: Kogelnik, HD and Sedlmayer, E, (eds.) Progress in Radio-oncology VI. (205 - 223). Monduzzi

E

Endicott, J and Noble, M and Lawrie, A and Tunnah, P and Brown, N and Johnson, L and Calvert, A and Curtin, N and Golding, B and Griffin, R and Newell, D (1998) Insights into CDK inhibitor design from X-ray crystallographic studies. ANN ONCOL , 9 3 - 3.

F

Flynn, AA and Green, AJ and Boxer, GM and Pedley, RB and Begent, RHJ (1998) A dosimetry model for the accurate characterisation of absorbed doses in mouse organs. British Journal of Cancer , 78 60 - 60.

Flynn, AA and Green, AJ and Boxer, GM and Pedley, RB and Begent, RHJ (1998) A dosimetry model for the accurate characterisation of absorbed doses in mouse organs. In: BRIT J CANCER. (pp. 39 - 39). CHURCHILL LIVINGSTONE

G

Geh, JI and Makris, A and Ashford, R and Grosch, E and GlynneJones, R (1998) Preoperative chemoradiotherapy for locally advanced rectal cancer. British Journal of Cancer , 78 23 - 23.

Gerrard, G and Short, S and C, (1998) The future of oncology training from the trainees' perspective. Clinical Oncology , 10 84 - 91.

Gibson, V and Anderson, RJ and Hartley, JA and Cairns, D (1998) Synthesis of anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcription. Annals of Oncology , 9 101 - 101.

Gibson, V and Anderson, RJ and Hartley, JA and Cairns, D (1998) Synthesis of anthraquinone-oligodeoxynucleotide conjugates as inhibitors of gene transcription. ANN ONCOL , 9 27 - 27.

Goodchild, KA and Hill, SA and Chaplin, DJ and Hoskin, PJ and Saunders, MI (1998) Modification of human tumour blood flow using pentoxifylline and carbogen. British Journal of Cancer , 78 45 - 45.

Grant, S and Boyle, F and Calvert, AH and Curtin, NJ and Endicott, J and Golding, BT and Griffin, RJ and Johnson, LN and Newell, DR and Noble, MEM and Robson, C (1998) O-6-alkylguanines as selective inhibitors of cyclin dependent kinases. Annals of Oncology , 9 523 - ?.

Griffin, RJ and Srinivasan, S and Bowman, K and Calvert, AH and Curtin, NJ and Newell, DR and Pemberton, LC and Golding, BT (1998) Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). J MED CHEM , 41 (26) 5247 - 5256.

H

Harland, SJ and Cook, PA and Fossa, SD and Horwich, A and Mead, GM and Parkinson, MC and Roberts, JT and Stenning, SP (1998) Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: Defining a high risk group. J UROLOGY , 160 (4) 1353 - 1357.

Harland, SJ and Linke, J and Kliesch, S and Looijenga, L and Dieckmann, KP and Grigor, K and Skakkebaek, NE and Jacobsen, GK and vonEyben, FE and Heidenriech, A and Wanderas, EH and Daugaard, G and Timmer, A and Oosterhuis, JW (1998) The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: The recent German experience -Discussion. Apmis , 106 20 - 23.

Harland, SJ and Nicholson, PW (1998) Implications of a hereditary model for testis cancer. In: Jones, WG and Appleyard, I and Harnden, P and Joffe, JK, (eds.) Germ Cell Tumours IV. (17 - 25). John Libbey & Co. Ltd.

Hartley, JM and Spanswick, VJ and Gander, M and Giacomini, G and Whelan, J and Souhami, RL and Hartley, JA (1998) Detection of DNA interstrand crosslinking in clinical samples using the single cell COMET assay. Annals of Oncology , 9 645 - 645.

Hartley, JM and Spanswick, VJ and Gander, M and Giacomini, G and Whelan, J and Souhami, RL and Hartley, JA (1998) Detection of DNA interstrand crosslinking in clinical samples using the single cell COMET assay. ANN ONCOL , 9 169 - 169.

Hartley, JM and Spanswick, VJ and Gander, M and Giacomini, G and Whelan, JS and Souhami, RL and Hartley, JA (1998) Detection of DNA interstrand crosslinking in clinical samples using the single cell COMET assay. In: 10th NCI-EORTC symosium on new drugs. Ann Oncol 1998; 9 (suppl 2):169.

Henderson, ND and Lacy, SM and O'Hare, CC and Hartley, JA and McClean, S and Wakelin, LPG and Kelland, LR and Robins, DJ (1998) Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA. ANTI-CANCER DRUG DES , 13 (7) 749 - 768.

Hochhauser, D (1998) Arsenic compound effective in leukaemia. LANCET , 351 (9108) 1037 - 1037.

Hochhauser, D (1998) Molecular biologists map pathways to gastrointestinal cancer. LANCET , 351 (9109) 1109 - 1109.

Holford, J and Raynaud, F and Murrer, BA and Grimaldi, K and Hartley, JA and Abrams, M and Kelland, LR (1998) Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473). ANTI-CANCER DRUG DES , 13 (1) 1 - 18.

Hoskin, PJ (1998) Major advances in the management of metastatic bone pain. UNSPECIFIED

Hoskin, PJ (1998) Palliativtherapie. In: Schmitt, G and Pape, H and Doker, RD, (eds.) Diagnostik und Interdisziplinare Therapie maligner Tumoren-Eine Einfuhrung fur Studierende und Arzte-Herausgeber. Unimed Verlag, Lorch/Bremen

Hoskin, PJ and Makin, W (1998) Oncology for Palliative Medicine. Oxford University Press

Hoskin, PJ and Rembowska, A (1998) Dosimetry rules for brachytherapy using high dose rate remote afterloading implants. CLIN ONCOL , 10 226 - 230.

Hoskin, PJ and Saunders, MI and Goodchild, K and Powell, MEB and Taylor, J and Baddeley, H (1998) Dynamic contrast enhanced magnetic resonance scanning to predict outcome after radiotherapy for head & neck cancer. British Journal of Cancer , 78 15 - 15.

Hughes, AN and Griffin, MJ and Calvert, AH and Johnston, A and Kerr, B and Lee, C and Newell, DR and Boddy, AV (1998) Pharmacokinetic interactions in a phase I study of nolatrexed (AG337, THYMITAQ (TM)) and paclitaxel in patients with advanced solid tumours. Annals of Oncology , 9 463 - ?.

J

Jackman, AL and Mitchell, F and Lynn, S and Aherne, GW and Rees, C and Calvert, AH and Judson, IR and Diab, S and Mayne, K and Smith, M (1998) Evidence for the duration of the antifolate action of the thymidylate synthase (TS) inhibitor ZD9331 using plasma dUrd as a surrogate marker of enzyme inhibition. Annals of Oncology , 9 604O - ?.

Jackson, H and Bacon, L and Pedley, RB and Derbyshire, E and Field, A and Osborn, JAA and D, (1998) Antigen specificity and tumour targeting efficiency of a human CEA specific scFv and affinity matured derivatives. British Journal of Cancer , 78 181 - 188.

Jackson, H and Bacon, L and Pedley, RB and Derbyshire, E and Field, A and Osbourn, J and Allen, D (1998) Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives. BRIT J CANCER , 78 (2) 181 - 188.

Jayson, GC and Middleton, M and Lee, SM and Ashcroft, L and Thatcher, N (1998) A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer. British Journal of Cancer , 78 (3) 366 - 369.

Ju, JF and Banerjee, D and Lenz, HJ and Danenberg, KD and Schmittgen, TC and Spears, CP and Schonthal, AH and Manno, DJ and Hochhauser, D and Bertino, JR and Danenberg, PV (1998) Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity. CLIN CANCER RES , 4 (5) 1315 - 1322.

Judson, I and Maughan, T and Beale, P and Primrose, J and Hoskin, P and Hanwell, J and Berry, C and Walkers, M and Sutcliffe, F (1998) Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694). British Journal of Cancer , 78 1188 - 1193.

K

Kakouri, E and Whelan, JS and Coltart, S and Smith, MEF and Souhami, RL (1998) Multifocal, multicentric Angiosarcoma of bone. Sarcoma , 1 183 - 188.
An open access publication

Koberle, B and Masters, JRW and Hartley, JA and Wood, RD (1998) Reduced Capacity for initial stages of nuceotide excision repair in two testis tumour cell lines. PROC AM ASSOC CANCER RES , 39 535 - 535.

Konishi, H and Ochiya, T and Chester, KA and Begent, RHJ and Muto, T and Sugimura, T and Terada, M (1998) Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody. Human Gene Therapy , 9 235 - 248.

Kretser, D and Giwercman, A and Heidenreich, A and Oliver, RTD and Kliesch, S and Harland, SJ and Lauke, H (1998) Gonadal function in men with testicular cancer: Biological and clinical aspects - Discussion. Apmis , 106 34 - 36.

Kupchinsky, S and Espinosa, JE and Johnson, K and Steadman, B and Brooks, N and Hartley, JA and Lee, M (1998) Design, synthesis and DNA binding properties of a series of 4,5-bis(substituted)-1,2,3-triazole derivatives of imidazole- and pyrrole-containing analogs of distamycin. HETEROCYCL COMMUN , 4 (5) 415 - 422.

L

Lee, SM and Radford, JA and Dobson, L and Huq, T and Ryder, WDJ and Pettengell, R and Morgenstern, GR and Scarffe, JH and Crowther, D (1998) Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost. British Journal of Cancer , 77 (8) 1294 - 1299.

M

Maini, MK and Wedderburn, LR and Hall, FC and Wack, A and Casorati, G and Beverley, PCL (1998) Comparison of two techniques for the molecular tracking of specific T-cell responses; CD4(+) human T-cell clones persist in a stable hierarchy but at a lower frequency than clones in the CD8(+) population. IMMUNOLOGY , 94 (4) 529 - 535.

Makris, A and Powles, TJ and Allred, DC and Ashley, S and Ormerod, MG and Titley, JC and Dowsett, M (1998) Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response. Breast Cancer Research And Treatment , 48 11 - 20.

Makris, A and Powles, TJ and Ashley, SE and Chang, J and Hickish, T and Tidy, VA and Nash, AG and Ford, HT (1998) A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Annals of Oncology , 9 1179 - 1184.

Makris, A and Powles, TJ and Titley, J and Trott, PA and Ormerod, MG (1998) Evidence for metastases to a single axillary lymph node from two separate primary breast carcinomas. Breast , 7 173 - 176.

Marshman, E and Calvert, AH and Newell, DR and Curtin, NJ (1998) Dipyridamole selectively potentiates antipurine antifolates in human tumour cell lines but not normal tissue targets of dose-limiting toxicity. Annals of Oncology , 9 589 - ?.

Marshman, E and Newell, DR and Calvert, AH and Dickinson, AM and Patel, HRH and Campbell, FC and Curtin, NJ (1998) Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro. CLIN CANCER RES , 4 (11) 2895 - 2902.

Mayer, A and Boxer, GM and O'Malley, D and Tsiompanou, E and Flynn, AA and Davidson, BR and Winslet, MC and Lewis, AAM and Dhillon, AP and Hilson, AJW and Begent, RHJ (1998) An anti-CEA single chain Fv antibody for radioimmunoguided surgery in colorectal cancer. ANN ONCOL , 9 35 - 35.

Mayer, A and Chester, KA and Bhatia, J and Pedley, RB and Read, DA and Boxer, GM and Begent, RHJ (1998) Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: Preparation of a genetically engineered anti-CEa single chain Fv antibody. EUR J CANCER , 34 (7) 968 - 976.

McAdam, SR and Knox, RJ and Hartley, JA and Masters, JRW (1998) KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithio-ethyl] mitomycin C): DNA interactions and drug uptake following serum activation. BIOCHEM PHARMACOL , 55 (11) 1777 - 1783.

McDonald, AC and Vasey, PA and Adams, L and Walling, J and Woodworth, JR and Abrahams, T and McCarthy, S and Bailey, NP and Siddiqui, N and Lind, MJ and Calvert, AH and Twelves, CJ and Cassidy, J and Kaye, SB (1998) A Phase I and pharmacokinetic study of LY231514, the multitargeted antifolate. CLIN CANCER RES , 4 (3) 605 - 610.

Mead, GM and Russell, M and Clark, P and Harland, SJ and Harper, PG and Cowan, R and Roberts, JT and Uscinska, BM and Griffiths, GO and Parmar, MKB (1998) A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. British Journal of Cancer , 78 1067 - 1075.

Meyer, T and Hart, IR (1998) Mechanisms of tumour metastasis. Eur.J.Cancer , 34 (2) 214 - 221.

Meyer, T and Marshall, JF and Hart, IR (1998) Expression of alphav integrins and vitronectin receptor identity in breast cancer cells. Br.J.Cancer , 77 (4) 530 - 536.

Middleton, MR and Lorigan, P and Lee, SM and Yip, D and Davies, J and Harper, P and Thatcher, N (1998) Dacarbazine, BCNU, cisplatin and tamoxifen (DBCT) v dacarbazine and interferon (DTIC/Ifn) in advanced melanoma: results of a randomised phase lll study. In: (Proceedings) 1998 ASCO Annual Meeting/34th Annual Meeting, Los Angeles, CA.. (pp. 508a - ?). Proceedings of the American Society of Clinical Oncology

Middleton, MR and Lunn, JM and Morris, C and Rustin, G and Wedge, SR and Brampton, MH and Lind, MJ and Lee, SM and Newell, DR and Bleehen, NM and Newlands, ES and Calvert, AH and Margison, GP and Thatcher, N (1998) O-6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. BRIT J CANCER , 78 (9) 1199 - 1202.

Middleton, MR and Lunn, JM and Morris, C and Rustin, G and Wedge, SR and Brampton, MH and Lind, MJ and Lee, SM and Newell, DR and Bleehen, NM and Newlands, ES and Calvert, AH and Margison, GP and Thatcher, N (1998) O-6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. British Journal of Cancer , 78 (9) 1199 - 1202.

Mitchell, F and Lynn, S and Rees, C and Judson, I and Calvert, AH and Ratain, M and Diab, S and Rowinsky, E and Mayne, K and Jackman, AL (1998) Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331. Annals of Oncology , 9 614 - ?.

O

Ornadel, D and Ledermann, JA and Eagle, K and Pedley, RB and Boxer, G and Ward, SE and Olabiran, Y and Bomanji, J (1998) Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small cell lung cancer. BRIT J CANCER , 77 (1) 103 - 109.

Ornadel, D and Ledermann, JA and Eagle, K and Pedley, RB and Boxer, G and Ward, SE and Olabiran, YAB and J, (1998) Biodistribution of a radiolabeled monoclonal antibody NY3D11 recognizing the neural crest adhesion molecule in tumour xenografts and patients with small-cell lung cancer. British Journal of Cancer , 77 103 - 109.

P

Page, D and Ekbom, A and Skakkebaek, NE and Rorth, M and Harland, SJ and Hardell, L and Auger, J and Vistisen, K (1998) Increasing incidence of testicular cancer - birth cohort effects - Discussion. Apmis , 106 229 - 231.

Patrick, MR and Chester, KA and Pietersz, GA (1998) In vitro characterization of a recombinant P-32-phosphorylated anti- (carcinoembryonic antigen) single-chain antibody. Cancer Immunology, Immunotherapy , 46 229 - 237.

Pedley, RB and Sharma, SK and Boden, R and Boxer, GM and Springer, CJ and Begent, RHJ (1998) Enhancement of adept with anti-vasculature drugs in a xenograft model. British Journal of Cancer , 78 106 - 106.

Pedley, RB and Sharma, SK and Boden, R and Boxer, GM and Springer, CJ and Begent, RHJ (1998) Enhancement of adept with anti-vasculature drugs in a xenograft model. BRIT J CANCER , 78 51 - 51.

Pedley, RB and Sharma, SK and Boden, R and Boxer, GM and Springer, CJAB and R, HJ (1998) Enhancement of ADEPT with anti-vascular drugs in a xenograft model. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 51 - ?).

Pietersz, GA and Patrick, MR and Chester, KA (1998) Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody. Journal of Nuclear Medicine , 39 47 - 56.

Plummer, R and Calvert, AH and Judson, I and Beale, P and Rees, C and Gokal, S and Highley, M and Lind, M and Smith, R and Hutchison, M and Mayne, K (1998) Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks. Annals of Oncology , 9 617 - ?.

Price, P and Hoskin, PJ and Hutchinson, T and Stenning, S and UK Med Res Council, (1998) What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? BRIT J CANCER , 78 (4) 504 - 507.

R

Rafi, I and Boddy, AV and Calvete, JA and Taylor, GA and Newell, DR and Bailey, NP and Lind, MJ and Green, M and Hines, J and Johnstone, A and Clendeninn, N and Calvert, AH (1998) Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors. J CLIN ONCOL , 16 (3) 1131 - 1141.

Rees, C and Beale, P and Plummer, R and Highley, M and Calvert, AH and Judson, I and Smith, R and Hutchison, M and Averbuch, S and Mayne, K (1998) Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks. Annals of Oncology , 9 628P - ?.

Roy, K and Chiao, JH and Spengler, BA and Tolner, B and Yang, CH and Biedler, JL and Sirotnak, FM (1998) Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter. CANCER GENET CYTOGEN , 105 (1) 29 - 38.

Roy, K and Tolner, B and Chiao, JH and Sirotnak, FM (1998) A single amino acid difference within the folate transporter encoded by the murine RFC-1 gene selectively alters its interaction with folate analogues - Implications for intrinsic antifolate resistance and directional orientation of the transporter within the plasma membrane of tumor cells. J BIOL CHEM , 273 (5) 2526 - 2531.
An open access publication

S

Saunders, MI (1998) CHART: The results and the relevance to clinical practice. In: Kogelnik, HD and Sedlmayer, E, (eds.) Progress in Radio-Oncology VI. (753 - 767). Monduzzi

Saunders, MI and Rojas, A and Lyn, BE and Pigott, K and Powell, M and Goodchild, K and Hoskin, PJ and Phillips, H and Verma, N (1998) Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non small cell lung cancer. British Journal of Cancer , 78 1323 - 1328.

Shaaaaarma, SK and Bhatia, J and Pedley, RB and Read, DA and Michael, P and Boden, RW and Chester, KA and Begent, RHJ (1998) Biodistribution of enzyme activity of a fusion protein for use in ADEPT. In: (Proceedings) British Journal of Cancer. (pp. 48 - 48).

Shah, N and Hoskin, P and Saunders, M and Novell, R and Makris, A (1998) Low dose Folinic acid with bolus and infusional 5 Fluorouracil chemotherapy in advanced colorectal carcinomas. British Journal of Cancer , 78 62 - 62.

Sharma, SK and Bhatia, J and Pedley, RB and Read, DA and Michael, P and Boden, RW and Chester, KA and Begent, RHJ (1998) Biodistribution of enzyme activity of a fusion protein for use in ADEPT. In: British Journal of Cancer. (pp. 48 - 48).

Sharma, SK and Bhatia, J and Pedley, RB and Read, DA and Michael, P and Boden, RW and Chester, KA and Begent, RHJ (1998) Biodistribution of enzyme activity of a fusion protein for use in ADEPT. British Journal of Cancer , 78 48 - 48.

Sharma, SK and Bhatia, J and Pedley, RB and Read, DA and Michael, P and Boden, RW and Chester, KA and Begent, RHJ (1998) Biodistribution of enzyme activity of a fusion protein for use in ADEPT. BRIT J CANCER , 78 14 - 14.

Sharma, SK and Bhatia, J and Pedley, RB and Read, DA and Michael, P and Chester, KAAB and R, HJ (1998) In vivo enzyme activity of a fusion protein for use in ADEPT. In: (Proceedings) Proceedings Americal Association for Cancer Research. (pp. 277 - ?).

Short, S (1998) UNSPECIFIED In: (Proceedings) Low dose effects.

Short, S (1998) UNSPECIFIED In: (Proceedings) The British Institute of Radiology 'New ideas in fractionation'.

Short, S and C, J and M, (1998) Cellular response to low-dose irradiation. Clinical Oncology , 10 73 - 78.

Singer, JM and Hartley, JM and Brennan, C and Nicholson, PW and Souhami, RL (1998) The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study. British Journal of Cancer , 77 978 - 984.

Smith, PG and Newell, DR and Barnes, MJ and Calvert, AH and Curtin, NJ (1998) Potentiation of the in vitro activity of the multi-targeted antifolate MTA (LY231514) by dipyridamole. Annals of Oncology , 9 588 - ?.

Smyth, J and Schellens, J and Kerger, J and Calvert, H and Bruntsch, U and Hanauske, A and EORTC Early Clinical Studies Grp, (1998) LU 103793 has activity in melanoma patients. ANN ONCOL , 9 116 - 116.

Spanswick, VJ and Cummings, J and Ritchie, AA and Smyth, JF (1998) Pharmacological determinants of the antitumour activity of mitomycin C. BIOCHEM PHARMACOL , 56 (11) 1497 - 1503.

Spanswick, VJ and Cummings, J and Smyth, JF (1998) Current issues in the enzymology of mitomycin C metabolic activation. GEN PHARMACOL-VASC S , 31 (4) 539 - 544.

Sunters, A and Grimaldi, KA and Souhami, RL and Hartley, JA (1998) Gene and human tumour cell line specific differences in nitrogen mustard induced DNA alkylation and interstrand crosslinking frequencies. NUCLEIC ACIDS RES , 26 (24) 5617 - 5623.
An open access publication

T

Thatcher, N and Lee, SM and Woll, PJ and Middleton, M and Anderson, H and Burt, P and Stout, R (1998) Dose intensity in small cell lung cancer. Seminars in Oncology , 25 (2) 12 - 18.

Tilby, MJ and McCartney, H and Gould, KA and O'Hare, CC and Hartley, JA and Hall, AG and Golding, BT and Lawley, PD (1998) A monofunctional derivative of melphalan: Preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts. CHEM RES TOXICOL , 11 (10) 1162 - 1168.

Tolner, B and Roy, K and Sirotnak, FM (1998) Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5 ' end heterogeneity. GENE , 211 (2) 331 - 341.

W

Watson, R and Boxer, GM and Jones, A (1998) Quantitation of CEA and oestrogen receptor expression in human breast cancers by radioimmunoluminography. BRIT J CANCER , 78 59 - 59.

Whelan, JS (1998) Bone tumours- Diagnosis, management and prognosis. Current Paediatrics , 8 31 - 36.

Whelan, JS and Burcombe, RJ and Cassoni, AM (1998) Systematic review of prophylactic lung irradiation in Osteosarcoma and Ewing's sarcoma. In: 4th Symposium of the Connective Tissue Oncology Society, Vancouver Nov 1998.

Z

Zilch, CF and Walker, AM and Timon, M and Goff, LK and Wallace, DL and Beverley, PCL (1998) A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. EUR J IMMUNOL , 28 (1) 22 - 29.

This list was generated on Mon May 20 07:00:25 2013 BST.